FierceBiotechFierceBiotechResearchFierceBiotechITFierceVaccinesFiercePharmaFiercePharmaManufacturing   FierceHealthcare
Related Tags >> Avastin   Genentech   FDA   Phase III
Syndicate content

colon cancer News

Most Popular colon cancer Story

Roche dealt setback as Avastin misses trial goal

Roche's stock dropped 10 percent in Swiss trading following the announcement that Avastin did not meet the primary endpoint in a highly-anticipated Phase III trial. The trial tested whether Avastin... Read more...

Latest Headlines